Endosomes are now recognized as important sites for regulating signal transduction. Here we show that the lipid kinase phosphatidylinositol 4-kinase III beta (PI4KIIIβ) regulates both endocytic kinetics and receptor signaling in breast cancer cells. PI4KIIIβ generates phosphatidylinositol 4-phosphate from phosphatidylinositol and is highly expressed in a subset of breast cancers. However, the molecular mechanism by which PI4KIIIβ promotes breast cancer is unclear. We demonstrate that ectopic PI4KIIIβ expression increases the rates of both endocytic internalization and recycling. PI4KIIIβ deletion reduces endocytic kinetics accompanied by a concomitant decrease in activity of the Rab11a GTPase, a protein required for endocytic function. Finally, we find that PI4KIIIβ activates IGF-IRβ signaling dependent on endosome function. Regulation of endocytic function by PI4KIIIβ is independent of its kinase activity but requires interaction with the Rab11a. This suggests that PI4KIIIβ controls endosomal kinetics and signaling by directly modulating Rab11a function. Our work suggests a novel regulatory role for PI4KIIIβ in endosome function and plasma membrane receptor signaling.
INTRODUCTION
Phosphatidylinositol 4-kinase III beta (PI4KIIIβ) generates phosphatidylinositol 4-phosphate (PI4P) from phosphatidylinositol (PI) and the protein has a well-characterized role in the maintenance of the structure and function of the Golgi 2, 3, 10 . Recent evidence suggests that PI4KIIIβ has a direct role in the progression and development of cancer 43 . For example, transcriptional analysis of 1992 primary human breast tumours by Curtis et al. identified PI4KB, the gene encoding human PI4KIIIβ, as a cancer driver gene due to its frequent gene amplification and overexpression in primary tumour tissue 7 . Additionally, we have reported that the PI4KIIIβ protein is highly expressed in ~20% of primary human breast tumours 28 .
Consistent with a functional role for PI4KIIIβ in cancer, ectopic PI4KIIIβ expression also disrupts three-dimensional epithelial morphogenesis of breast cells and promotes cell motility and actin remodeling 1, 20, 31 . Finally, our lab has reported that PI4KIIIβ is able to directly activate Akt signaling 28 .
PI4KIIIβ has kinase-independent functions and could therefore regulate cancer progression through mechanisms distinct from PI4P generation. In Drosophila, for example, the PI4KIIIβ homolog four-wheel drive (Fwd) regulates Rab11localization and endocytic function independent of PI4P 32 . Rab11a is a member of the Rab family of small GTPases that control membrane identity and function in the endocytic system 39 . PI4KIIIβ directly binds Rab11 5 and
Fwd/Rab11interaction is necessary for normal cytokinesis in Drosophila spermatocytes and loss of Fwd leads to sterility in males 32 . In yeast and mammalian cells, PI4KIIIβ is similarly necessary for the binding and localization of Rab11a to the Golgi independent of PI4P 9, 32 . Additionally, PI4KIIIβ-mediated activation of Akt requires Rab11a interaction but not an active lipid kinase domain 28 . Taken together, PI4KIIIβ appears to have an important functional relationship with Rab11a and endosome function independent of its ability to generate PI4P.
The endocytic system is best known for moving cargo to and from the plasma membrane 23 . In addition, by controlling both plasma membrane abundance and degradation of signalling receptors, the endocytic system controls both activation, propagation and timing of signalling cascades downstream tumorigenic receptors 37, 38, 40 . For example, in endosomes the ligand-bound epidermal growth factor receptor (EGFR) and the small GTPase Rab5 recruit the adaptor protein APPL promoting the activation of Akt 24, 35 . We have previously shown that the interaction between PI4KIIIβ and Rab11a is required for activation of Akt signaling 28 . We therefore hypothesized that the interaction between PI4KIIIβ and endosomes is related to its role PI4KIIIβ in oncogenesis. Here we find that PI4KIIIβ regulates both endocytosis and recycling of surface receptors affecting Rab11a activation. Our findings suggest that PI4KIIIβ has an important role in endosome function and endosome-mediated signaling in cancer cells.
RESULTS

PI4KIIIβ regulates mammary tumourigenesis.
We have previously shown that PI4KIIIβ protein is highly expressed in a ~20% fraction of human breast cancers 28 . In order to determine whether or not PI4KIIIβ might have a role in primary mammary tumour development, we used CRISPR/Cas9 to delete Pi4kb, the mouse PI4KIIIβ homolog, from the mouse mammary 4T1
tumour cell line ( Figure 1 ). 4T1 is a metastatic derivative of a spontaneous mammary tumour from Balb/c mice 33 . When injected into the mammary fat pad of syngeneic mice they grow as solid tumours and this model is commonly used to study in vivo mammary tumour growth 26 .
Two independent lines of 4T1 that lack Pi4kb grow substantially slower than control cells (Figures 1a-d) . Re-expression of human PI4KIIIβ in the Pi4kb null cells returns tumorigenicity to wildtype levels ( Figure 1e ). These results are consistent with the idea that PI4KIIIβ function has an important functional role in mammary tumour development.
PI4KIIIβ activates IGF-IRβ. We hypothesized that PI4KIIIβ is oncogenic through an ability to activate receptor signaling. We have previously reported that ectopic expression of PI4KIIIβ
activates Akt in a kinase-independent manner in breast cell lines 28 . To determine whether or not PI4KIIIβ affects signaling pathways in addition to Akt, we expressed ectopic wildtype or kinase-inactive (D656A) PI4KIIIβ in BT549 human breast ductal carcinoma cells (Figure 2a ). We observed a significant 2-3-fold increase in IGF-IRβ activation when either wild-type or kinaseinactive PI4KIIIβ was highly expressed compared to controls (Figures 2b and c) . This demonstrates that PI4KIIIβ activates in IGF-IRβ signaling in a manner that does not require an active lipid kinase domain.
PI4KIIIβ expression alters endocytic kinetics. The activation of Akt by PI4KIIIβ previously established by our lab was shown to be dependent upon the presence of Rab11a
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. Because
Rab11a regulates endosome recycling, we hypothesized that the effects of PI4KIIIβ on breast cancer oncogenesis may be due to a regulatory role in endosome function 23 . To determine whether PI4KIIIβ might affect transport of surface receptors from endosomes to plasma membrane, we used transferrin pulse-chase assays to measure the rate of endocytic recycling.
We observed that BT549 cells overexpressing wildtype or kinase-inactive PI4KIIIβ were able to recycle out twice as much internalized transferrin as the vector control (Figures 3a and b ).
Transferrin receptor expression is similar between the cell lines (Supplementary Figure 1) and recycling kinetics are normalized for each cell line to account for small differences in initial transferrin binding to the cell surface. Next, we used transferrin uptake assays to measure the rate at which cells were able to internalize fluorescent transferrin. BT549 cells with ectopic wildtype or kinase-inactive PI4KIIIβ were able to internalize significantly more transferrin (4-5x) than the vector control (Figures 3c and d) . Uptake kinetics were normalized for each cell line to account for any difference in initial transferrin binding to the cell surface.
To further explore the importance of PI4KIIIβ on endosome function, we created PI4KB-null cell lines using CRISPR/Cas9 in BT549 wildtype cells (Figure 4a ). PI4KB-null cells are viable and appear to proliferate normally. Perhaps surprisingly, we did not observe any disruption of the gross morphology of either the cis-or trans-Golgi in PI4KB-null cells (Figures 4b and c) Figure S2) . Overall, our results are consistent with a novel role for PI4KIIIβ in controlling endocytic internalization and recycling.
Lipid kinase-independent control of endocytic function. PI4KIIIβ is a multifunctional protein and we next wanted to determine which of the documented roles of PI4KIIIβ are involved in regulating endocytic function. To this end, we expressed wild-type, kinase-inactive (D656A) and Rab11a-binding deficient (N162A) PI4KIIIβ in the BT549 PI4KB-null CRISPR/Cas9 cell lines ( Figure   5a ). We then used the transferrin pulse-chase and uptake assays to measure the efficiency of both receptor internalization and recycling. We found that the reintroduction of wildtype and kinase-inactive PI4KIIIβ was able to rescue the rate of transferrin recycling (Figures 5b and c) .
However, the Rab11a-binding deficient PI4KIIIβ was unable to do so (Figures 5b and c) . This is consistent with the idea that endocytic recycling by PI4KIIIβ does not require lipid kinase activity but is dependent upon the functional interaction between PI4KIIIβ and Rab11a.
On the other hand, we found that the rate of transferrin uptake was only fully rescued if the reintroduced PI4KIIIβ was catalytically active and able to interact with Rab11a (Figures 5d and e). In the absence of endogenous PI4KIIIβ, kinase-inactive or Rab11a-binding deficient PI4KIIIβ resulted in only a partial (~30-50%) rescue of the transferrin uptake rate (Figures 5d and e). This is in contrast to those obtained with recycling, where we observed a similar increase in recycling between wildtype and kinase-inactive PI4KIIIβ (Figures 5b and c) . This could be due to the lower levels of kinase-inactive PI4KIIIβ expression in our PI4KB-null rescue cell lines compared to the amount of wildtype PI4KIIIβ (Figure 5a ). However, this lower level of kinase-inactive PI4KIIIβ expression fully rescued recycling. We propose that the kinasedependent and -independent functions of PI4KIIIβ may cooperate in regulating endosome internalization.
PI4KIIIβ is found in some endosomal compartments. We and others have previously reported that ectopically expressed PI4KIIIβ, both wildtype and kinase-inactive, colocalizes with Rab11a in recycling endosome 28 . Purified PI4KIIIβ and Rab11a proteins bind each other with 1:1 stoichiometry
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. Since we have found that PI4KIIIβ has an impact on both endocytic recycling and internalization, we speculated that PI4KIIIβ might be found in endocytic compartments. To test this idea, we used immunofluorescence to determine whether or not PI4KIIIβ could be found in early or late endosomes. As shown in Figure 6 , PI4KIIIβ can be found in early 
DISCUSSION
In this study, we establish an important role for PI4KIIIβ in the regulation of the endocytic system. We show that PI4KIIIβ expression increases the rates of both internalization and recycling of transferrin. PI4KIIIβ deletion has the opposite effect, decreasing both internalization and recycling rates. Furthermore, loss of PI4KIIIβ decreases cellular Rab11a activity, suggesting that PI4KIIIβ-mediated control of endocytosis is mediated by regulating Rab11a function. Importantly, a kinase-inactive version of PI4KIIIβ rescues normal recycling in PI4KIIIβ-null cells, indicating that PI4KIIIβ-dependent control of recycling is independent of lipid kinase activity.
The PI4KIIIβ protein is highly expressed and the PI4KB gene amplified in a subset of primary human breast tumours 7, 28 . In addition, high PI4KIIIβ expression disrupts normal breast epithelial morphogenesis, resulting in irregular polarization and formation of multi-acinar structures 31 . PI4KIIIβ has also been identified as a downstream effector of the known breast and ovarian cancer oncogene eEF1A2 and is involved in actin remodeling and cell motility 1, 19 .
Here, we find that deletion of PI4KIIIβ decreases the rate of tumour development in mice. This observation is consistent with the idea that PI4KIIIβ is a breast cancer oncogene.
PI4KIIIβ-Rab11a interaction is required for PI4KIIIβ-mediated regulation of endosome function since a Rab11a binding mutant is unable to rescue recycling in PI4KIIIβ-null cells.
Rab11a is necessary for the transport of recently internalized endosomes from the plasma membrane to the trans-Golgi network and the 'slow' recycling of internalized endosomes back to the plasma membrane [44] [45] [46] . Rab11a regulates these processes by directly binding effector proteins and recruiting them to endosomal vesicles. The PI4KIIIβ protein binds directly to Rab11a 5 and has previously been shown to be required for the proper intracellular localization of Rab11 9, 32 . We observed that loss of PI4KIIIβ causes a drop in the overall Rab11a cellular activity as measured by Rab11 FRET biosensor. This is consistent with the idea that PI4KIIIβ is a direct activator of Rab11a. We hypothesize that PI4KIIIβ stabilizes interaction between GTPloaded Rab11a and its effectors and thus promotes endosomal function. This potentiation of Rab11a activity would be independent of PI4KIIIβ lipid kinase activity. In cells with high levels of PI4KIIIβ, as would occur in approximately 20% of breast tumours, we hypothesize that increased number of PI4KIIIβ-Rab11a complexes increases the rate of endosome maturation, causing rapid delivery of internalized endosomes to the plasma membrane. Further work will be necessary to identify the Rab11a effectors involved.
Ectopic PI4KIIIβ expression not only increases the rate of the endocytic transport but also the activation of IGF-IRβ and Akt 28 . For IGF-IRβ, this activation is dependent on endosome function. We propose that PI4KIIIβ-mediated increase of endocytic rates amplifies the activation of plasma membrane signaling. Activation of of receptor tyrosine kinases (RTKs) and G-protein coupled receptors (GPCRs) is closely linked with the endocytic system 17, 45 . Following extracellular ligand-induced activation, the activated receptor complex enters the cell via clathrin-dependent endocytosis 12, 17 . Once internalized, activated receptor complexes may enter signaling endosomes 37, 38 . Here, the recruitment of adaptor proteins promotes the initiation of intracellular signaling events unique to endosomes 37, 38 . For example, in an early endosome containing activated EGFR, Rab5 will recruit APPL proteins to interact with Rab5 and EGFR; this will, in turn, promote the activation of Akt 24, 35 .
We propose that efficient endocytic recycling modulates signalling downstream IGF-IRβ. This is based on the finding that IGF-IRβ phosphorylation require PI4KIIIβ-mediated receptor recycling and a fully functional clathrin mediated endocytosis. Our model for PI4KIIIβ function is that in cancer cells with high PI4KIIIβ expression, activated receptor complexes are rapidly internalized and recycled back to the plasma membrane by trafficking into a PI4KIIIβ and Rab11a-positive endosome than in wildtype cells. Accordingly, increased number of PI4KIIIβ containing vesicles located near the periphery of the cell were measured. This process sustain the repeated activation of signaling events at the cell surface and in signaling endosomes. We propose that this endocytic-regulated control of signaling pathway activation contributes to the increased proliferation, survival and migration of those breast cancers with high PI4KIIIβ 42 .
Previous evidence has shown that the dysfunction of the endocytic system can contribute to the pathogenesis of cancer, through loose regulation of signaling events. For example, Rohatgi et al discovered a novel role for beclin 1 as a regulator of early endosome maturation 34 . They revealed that beclin 1, best characterized for its role in autophagy, regulates the maturation of early endosomes by recruiting phosphatidylinositol 3-phosphate (PI3P) in response to growth factor stimulation and that this control of early endosome maturation controls the duration of growth factor receptor signaling on endosomes 34 . The loss of BECN1 in breast tumours, was shown to cause sustained activation of Akt and ERK in breast cancer cells 13 . Additionally, endosomal sorting complexes required for transport (ESCRT) complexes sort endosomes and, through post-internalization modifications, target the endosomes for recycling or degradation 36 . The loss of activity in subunits of ESCRT complexes is often found in human cancers and has been shown to be sufficient for the development of metastatic tumours 21, 22 . Elevated Rab11a expression has been observed in multiple cancers and can promote cell migration in cancerous cells of the gut, skin and breast 14, 16, 18 . This suggests that Rab11a, and its activators and effectors, are likely to be oncogenes. However, this role may not be strictly universal since a recent report indicates that loss of Rab11a in mice promotes epithelial dysplasia of the intestine and reduced Rab11a expression is associated with poor survival in stage II and III colon cancers 8 .
We were surprised to see that PI4KIIIβ expression had an effect on endocytic internalization. Since Rab11a is not known to affect internalization, we believe that PI4KIIIβ is more extensively involved in the endocytic system than with just Rab11a and recycling endosomes. The Rab11a binding domain we disrupted in PI4KIIIβ (N162) interacts with Rab11a at a leucine residue that is conserved among other Rab proteins, including Rab5 and Rab7
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Rab5 controls the internalization of clathrin-coated pits 10 . Since we see a significant effect on transferrin internalization due to PI4KIIIβ expression, we hypothesize that PI4KIIIβ is acting with Rab5 to facilitate rapid internalization. This is consistent with our observation that PI4KIIIβ can be found in the same vesicles as Rab5. Additionally, termination of signaling is often achieved through the degradation of receptors and ligands via the late endocytic and lysosomal pathways 38 . As Rab7, which we also observed to be found in the vesicles with PI4KIIIβ, is concentrated on late endosomes and is crucial for endo-lysosomal trafficking, it could possibly be involved or affected by PI4KIIIβ-mediated regulation of endocytic kinetics and signaling 10, 37 .
Although PI4KIIIβ appears to have an important relationship with Rab11a, further work is necessary to determine how PI4KIIIβ and other endocytic regulatory proteins modify endocytic internalization. The importance of the PI4KIIIβ-Rab11a interaction in signaling activation suggests that this interface may be a druggable target for cancer therapy.
Long thought to simply be a way to move nutrients into and waste out of a cell, evidence is now emerging for the endocytic system as a regulator of cellular function and behaviour 25, 37, 38 . Studies implicate endocytosis in polarity, proliferation, migration, division, and transcription, among other cellular regulatory processes 11, 37, 38, 42, 47 . When appropriately regulated, this permits cells to survive in their environment and perform their intended functions. However, when regulation of the endocytic system is perturbed, this can lead to disruption in polarity, enhanced proliferation, abnormal migration, and uncontrolled division, ultimately leading to the development and progression of cancers 29, 37, 38 . Here, we reveal that 
